Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer

NCT00088985 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

56

Enrollment

OTHER

Sponsor class

Stopped Funding unavailable

Conditions

Breast Cancer

Interventions

BIOLOGICAL: therapeutic autologous dendritic cells
BIOLOGICAL: trastuzumab
DRUG: vinorelbine ditartrate

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]
[object Object]